Derwent

Wednesday February 12th 2020 11:00 am EST | Complimentary Webinar

Advancements in biotechnology have made the large-scale development of biological drugs easier and more cost-effective to develop. While chemical based drugs remain most prevalent, the total share of biologic drugs has increased significantly in recent years, representing more than 25% of the pharmaceutical market and more growth is expected with annual revenue to reach US$ 727 billion by 2025.

What do these growing trends mean for the industry at large? As a patent or research professional, you’re invited to hear Dr. Rose Hughes, European Patent Attorney at AstraZeneca, and Dr. Caroline Peel, Head of IP and Standards Content at Clarivate Analytics, discuss the trends shaping the biosequence technology landscape.

Leading technology areas in biosequence patents

Acquiring Innovation: building versus buying

Biotechnology hot spots around the globe

An analysis of global patent activity as a predictor for biologics growth

Dr. Rose Hughes, AstraZeneca

European Patent Attorney

Dr. Caroline Peel, Clarivate Analytics

Head of IP and Standards Content

PERSONAL

First Name*

Last Name*

Email Address*

BUSINESS

Job Title*

Job Role*

Business Phone*

Organization Name*

Organization Type*

LOCATION

City*

State or Province

Country/Region*

Please check this box to receive emails from Clarivate Analytics. You can unsubscribe at any time.

HIDDEN FIELDS BELOW

SBU of Lead

Primary Product

Sub Primary Products

Lead Source - Most Recent

Last Follow Up

Lead Routing

Lead Status

Marketing Lead Status

WEBINAR
Global Patent Trends in Biologics Innovation

We will be covering the following topics:

Featured speakers: